Decitabine, a hypomethylating agent, upregulated PD-1, PD-L1, PD-L2 and CTLA-4 protein and RNA transcription in leukemia patients and dose-dependently increased these same ligands in leukemia cell lines [158]. Here, CD274 is linked to leukemia.